Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
1 result for Superlist ID equals S900007530
Drug Name: Oncoprex
Description: Manufacturers Statsment: ... Oncoprex (TM), is a biologic therapy targeting key oncogenic pathways to treat tumors and cancer metastases at the molecular level. The active anti-cancer agent in Oncoprex is TUSC2, also known as FUS1, which is incorporated into nanovesicles and formulated for intravenous administration. TUSC2 was originally discovered as a tumor suppressor and was subsequently confirmed as a powerful pan-kinase inhibitor. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Sep 2019